Nova Tina Susan has filed 7 insider transactions across 3 companies since February 2023.
Most recent transaction: a grant/award of 5663 shares of Azenta, Inc. ($AZTA) on February 06, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 6, 2026 | Azenta, Inc. | $AZTA | Nova Tina Susan | Not found | A | Common | 5663 | $27.85 | 15,772.0000 | 45,929,000 | 56.02% | 0.01% |
| June 10, 2025 | EXAGEN INC. | $XGN | Nova Tina Susan | Director | A | Stock Option(right to buy) | 13500 | $0.00 | 13,500.0000 | 18,203,044 | 9999.99% | 0.07% |
| May 16, 2025 | Aurinia Pharmaceuticals Inc. | $AUPH | Nova Tina Susan | Director | A | Director Stock Option (right to buy) | 63724 | $0.00 | 63,724.0000 | 146,194,000 | 9999.99% | 0.04% |
| Feb. 7, 2025 | Azenta, Inc. | $AZTA | Nova Tina Susan | Not found | A | Common | 4040 | $52.32 | 10,109.0000 | 45,626,000 | 66.57% | 0.01% |
| June 10, 2024 | EXAGEN INC. | $XGN | Nova Tina Susan | Director | A | Stock Option(right to buy) | 13500 | $0.00 | 13,500.0000 | 17,679,467 | 9999.99% | 0.08% |
| Feb. 12, 2024 | Azenta, Inc. | $AZTA | Nova Tina Susan | Not found | A | Common | 2465 | $65.93 | 6,069.0000 | 56,709,000 | 28.88% | 0.00% |
| Feb. 13, 2023 | Azenta, Inc. | $AZTA | Nova Tina Susan | Director | A | Common Stock | 3604 | $0.00 | 3,604.0000 | 0 | 9999.99% | 0.00% |